Development Roadmap and Application Prospects of LIMS in Drug Testing Institutions under the “Artificial Intelligence Plus” Scenario

Zhang Weimin, Li Xiuji, Zhong Xuanwei

Chinese Pharmaceutical Affairs ›› 2026, Vol. 40 ›› Issue (4) : 367-374.

PDF(1049 KB)
PDF(1049 KB)
Chinese Pharmaceutical Affairs ›› 2026, Vol. 40 ›› Issue (4) : 367-374. DOI: 10.16153/j.1002-7777.2026-02-0005
Supervision & Administration

Development Roadmap and Application Prospects of LIMS in Drug Testing Institutions under the “Artificial Intelligence Plus” Scenario

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 40(4): 367-374 https://doi.org/10.16153/j.1002-7777.2026-02-0005

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1049 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉